A BILL 
To improve the quality, appropriateness, and effectiveness 
of diagnosis in health care, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Improving Diagnosis 
4
in Medicine Act of 2022’’. 
5
SEC. 2. RESEARCH PROGRAM TO IMPROVE DIAGNOSTIC 
6
SAFETY AND QUALITY. 
7
Part B of title IX of the Public Health Service Act 
8
(42 U.S.C. 299b et seq.) is amended by adding at the end 
9
the following: 
10
16:30 Jul 03, 2022
H8172
2 
•HR 8172 IH
‘‘SEC. 918. RESEARCH PROGRAM TO IMPROVE DIAGNOSTIC 
1
SAFETY AND QUALITY. 
2
‘‘(a) IN GENERAL.—The Director shall establish a 
3
comprehensive program of research and quality improve-
4
ment to— 
5
‘‘(1) assess and understand diagnostic errors, 
6
including diagnostic delays, and how to eliminate 
7
common failures in the diagnostic process that lead 
8
to significant patient harm; and 
9
‘‘(2) identify, develop, implement, and dissemi-
10
nate evidence-based strategies and best practices for 
11
improving diagnostic quality, safety, and health care 
12
value. 
13
‘‘(b) ACTIVITIES.—The program established under 
14
subsection (a) shall include the following: 
15
‘‘(1) CONTINUUM OF RESEARCH.—A portfolio 
16
of conducted and supported activities that is con-
17
sistent with the general, research, implementation, 
18
and dissemination activities of the Center for Qual-
19
ity Improvement and Patient Safety, as described in 
20
section 933, including— 
21
‘‘(A) investigator-initiated research to as-
22
sess diagnostic errors and identify improved 
23
methods to prevent errors and the harm they 
24
cause; 
25
16:30 Jul 03, 2022
H8172
3 
•HR 8172 IH
‘‘(B) translation and synthesis of research 
1
findings and development of tools for imple-
2
menting prevention strategies into practice; 
3
‘‘(C) implementation research to refine evi-
4
dence-based tools for improving diagnostic proc-
5
esses and effectively integrate these solutions 
6
into practice; and 
7
‘‘(D) dissemination to promote implemen-
8
tation of effective methods, strategies and tools 
9
for wide-scale improvement. 
10
‘‘(2) RESEARCH CENTERS OF DIAGNOSTIC EX-
11
CELLENCE.—Grants or contracts awarded to public 
12
or private entities, in geographically diverse locations 
13
throughout the United States, that link research di-
14
rectly with clinical practice and that may include— 
15
‘‘(A) academic medical and institutional re-
16
search centers that combine demonstrated mul-
17
tidisciplinary expertise in diagnostic outcomes 
18
or quality improvement research with linkages 
19
directly or through national, state or local 
20
stakeholder partner organizations to relevant 
21
sites of care; and 
22
‘‘(B) provider-based research networks, in-
23
cluding plan, facility, or delivery system sites of 
24
care (especially primary care), that can evaluate 
25
16:30 Jul 03, 2022
H8172
4 
•HR 8172 IH
outcomes and evaluate and promote quality im-
1
provement approaches. 
2
‘‘(3) FINANCIAL
ASSISTANCE.—The Director 
3
may provide financial assistance to assist in meeting 
4
the costs of planning and establishing new centers, 
5
as well as operating existing and new centers, pursu-
6
ant to section 902(c). 
7
‘‘(4) STAKEHOLDER
ENGAGEMENT.—The Di-
8
rector shall identify and enter into a supporting 
9
agreement (grant or contract) with a nonprofit enti-
10
ty that convenes a coalition of diverse health care 
11
stakeholders for the purpose of— 
12
‘‘(A) raising attention to diagnostic safety 
13
and quality concerns; 
14
‘‘(B) facilitating learning, adoption and 
15
spread of effective quality improvement inter-
16
ventions; and 
17
‘‘(C) catalyzing novel actions by individual 
18
member organizations to reduce harms from di-
19
agnostic error and improve patient outcomes. 
20
‘‘(c) AUTHORIZATION OF APPROPRIATIONS.— 
21
‘‘(1) IN GENERAL.—To carry out this section, 
22
there is authorized to be appropriated $20,000,000 
23
for fiscal year 2023, $25,000,000 for fiscal year 
24
16:30 Jul 03, 2022
H8172
5 
•HR 8172 IH
2024, $30,000,000 for fiscal year 2025, and 
1
$35,000,000 for each of fiscal years 2026 and 2027. 
2
‘‘(2) RESERVATION.—Of the amount appro-
3
priated under paragraph (1) for a fiscal year, 
4
$700,000 shall be allocated to carrying out the pur-
5
pose described in subsection (b)(4). 
6
‘‘(3) 
AVAILABILITY.—Amounts 
appropriated 
7
under this section shall remain available until ex-
8
pended.’’. 
9
SEC. 3. FELLOWSHIPS AND TRAINING GRANTS. 
10
(a) RUTH KIRCHSTEIN AWARDS.—Section 487(a) of 
11
the Public Health Service Act (42 U.S.C. 288(a)) is 
12
amended by adding at the end the following: 
13
‘‘(5) For purposes of the program under this sub-
14
section, biomedical and behavioral research includes diag-
15
nostic safety and quality research.’’. 
16
(b) AHRQ PROGRAMS.—Section 902(b)(1) of the 
17
Public Health Service Act (42 U.S.C. 299a(b)(1)) is 
18
amended— 
19
(1) by inserting ‘‘and diagnostic safety and 
20
quality’’ after ‘‘subsection (a)’’; and 
21
(2) by striking ‘‘under section 487(d)(3)’’ and 
22
inserting ‘‘for purposes of carrying out section 487’’. 
23
16:30 Jul 03, 2022
H8172
6 
•HR 8172 IH
SEC. 4. QUALITY MEASURE DEVELOPMENT. 
1
Section 931(c)(2) of the Public Health Service Act 
2
(42 U.S.C. 299b–31(c)(2)) is amended— 
3
(1) 
by 
redesignating 
subparagraphs 
(B) 
4
through (J) as subparagraphs (C) through (K), re-
5
spectively; and 
6
(2) by inserting after subparagraph (A) the fol-
7
lowing: 
8
‘‘(B) diagnostic safety and quality;’’. 
9
SEC. 5. DATA FOR RESEARCH AND IMPROVEMENT. 
10
Section 937(f) of the Public Health Service Act (42 
11
U.S.C. 299b–37(f)) is amended— 
12
(1) by striking ‘‘The Secretary’’ and inserting 
13
the following: 
14
‘‘(1) IN GENERAL.—The Secretary’’; and 
15
(2) adding at the end the following: 
16
‘‘(2) CONSULTATION WITH EXPERT PANEL.—In 
17
carrying out paragraph (1), the Secretary, in coordi-
18
nation with the Director, the Administrator of the 
19
Centers for Medicare & Medicaid Services, the Na-
20
tional Coordinator for Health Information Tech-
21
nology, and the Director of the National Library of 
22
Medicine, shall convene an expert panel to consider 
23
and make recommendations regarding the types, 
24
sources, and availability of data needed to accelerate 
25
diagnostic safety and quality research, training, and 
26
16:30 Jul 03, 2022
H8172
7 
•HR 8172 IH
measure development as specified in section 918, in-
1
cluding data related to racial, ethnic, and language 
2
attributes; gender, age, geography, and socio-
3
economic conditions; the specificity, interoperability, 
4
and socio-technical aspects of electronic vocabularies 
5
and ontologies related to presenting symptoms and 
6
diagnostic certainty; and the development and use of 
7
symptom-based clinical registries. Such panel shall 
8
consider enhanced data capabilities that are nec-
9
essary to support both research and improvement of 
10
diagnostic safety and quality.’’. 
11
SEC. 6. INTERAGENCY COUNCIL ON IMPROVING DIAGNOSIS 
12
IN HEALTH CARE. 
13
(a) ESTABLISHMENT.—The Secretary of Health and 
14
Human Services (in this section referred to as the ‘‘Sec-
15
retary’’) shall establish within the Office of the Secretary 
16
an interagency council to be known as the Interagency 
17
Council on Improving Diagnosis in Health Care (referred 
18
to in this section as the ‘‘Council’’). 
19
(b) OBJECTIVES.—The Council shall furnish a forum 
20
for the agencies represented on the Council to discuss 
21
ways to accomplish the following objectives: 
22
(1) Enhance the quality, appropriateness, and 
23
effectiveness of diagnosis in health care through— 
24
16:30 Jul 03, 2022
H8172
8 
•HR 8172 IH
(A) the establishment and support of a 
1
broad base of scientific research; 
2
(B) the dissemination and implementation 
3
of the results of such research; and 
4
(C) the promotion of improvements in clin-
5
ical and health system practices. 
6
(2) Identify and eliminate systemic barriers to 
7
supporting research in improving diagnosis in health 
8
care. 
9
(3) Identify knowledge gaps, research and data 
10
needs, and opportunities congruent with agency mis-
11
sions to strengthen the clinical and translational re-
12
search pipeline to improve diagnostic safety and 
13
quality, including potential collaborative research ini-
14
tiatives among 2 or more agencies, offices, institutes, 
15
or centers within the Department of Health and 
16
Human Services or other Federal agencies or offices. 
17
(c) MEMBERSHIP.— 
18
(1) CHAIRPERSON.—The Director of the Agen-
19
cy for Healthcare Research and Quality (or the Di-
20
rector’s designee) shall be the Chairperson of the 
21
Council. 
22
(2) MEMBERS.— 
23
16:30 Jul 03, 2022
H8172
9 
•HR 8172 IH
(A) IN
GENERAL.—In addition to the 
1
Chairperson, the Council shall be comprised of 
2
the following: 
3
(i) At least 1 designee from each of 
4
the following, appointed by the head of the 
5
applicable department or agency: 
6
(I) The Centers for Disease Con-
7
trol and Prevention. 
8
(II) The Centers for Medicare & 
9
Medicaid Services. 
10
(III) The Department of Vet-
11
erans Affairs. 
12
(IV) The Congressionally Di-
13
rected Medical Research Program of 
14
the Department of Defense. 
15
(V) The Office of the National 
16
Coordinator for Health Information 
17
Technology. 
18
(ii) Designees from the National Insti-
19
tutes of Health, including a least 1 des-
20
ignee from each of the following: 
21
(I) The National Cancer Insti-
22
tute. 
23
(II) The National Center for Ad-
24
vancing Translational Sciences. 
25
16:30 Jul 03, 2022
H8172
10 
•HR 8172 IH
(III) The National Institute of 
1
Allergy and Infectious Diseases. 
2
(IV) The National Heart, Lung, 
3
and Blood Institute. 
4
(V) The National Institute of 
5
Neurological Disorders and Stroke. 
6
(VI) The National Library of 
7
Medicine. 
8
(VII) The National Institute on 
9
Minority Health and Health Dispari-
10
ties. 
11
(VIII) The National Institute of 
12
Nursing Research. 
13
(IX) The Eunice Kennedy Shriv-
14
er National Institute of Child Health 
15
and Human Development. 
16
(iii) Designees from such other na-
17
tional research institutes and national cen-
18
ters as may be appropriate, as determined 
19
by the Director of the National Institutes 
20
of Health. 
21
(B) ADDITIONAL MEMBERS.—In addition 
22
to the designees under subparagraph (A), the 
23
Council may include such other designees from 
24
16:30 Jul 03, 2022
H8172
11 
•HR 8172 IH
Federal departments or agencies as the Chair-
1
person of the Council deems appropriate. 
2
(C) DESIGNATION.—A person appointed to 
3
the Council as a designee shall be a senior offi-
4
cial or employee of the department or agency 
5
whose responsibilities and subject matter exper-
6
tise are relevant to the Council’s objectives list-
7
ed in subsection (b), as determined by the des-
8
ignating official. 
9
(d) STRATEGIC PLAN; REPORTS.— 
10
(1) STRATEGIC FEDERAL PLAN TO IMPROVE DI-
11
AGNOSIS
IN
HEALTH
CARE.—Not later than 18 
12
months after the date of enactment of this Act, the 
13
Council shall develop, submit to the Secretary and 
14
Congress, and make publicly available a strategic 
15
plan, to be known as the Strategic Federal Plan to 
16
Improve Diagnosis. Consistent with the objectives 
17
listed in subsection (b), such strategic plan— 
18
(A) shall identify coordinated opportunities 
19
to enhance scientific research and reduce sys-
20
temic barriers in order to improve diagnosis in 
21
health care; and 
22
(B) shall include administrative policy rec-
23
ommendations, and may include such legislative 
24
recommendations as the Council may wish to 
25
16:30 Jul 03, 2022
H8172
12 
•HR 8172 IH
make, including recommendations on opportuni-
1
ties to remove barriers to, and enhance, inter-
2
agency coordination in the planning, conduct, 
3
and funding of, such research. 
4
(2) REPORTS TO CONGRESS.—Not later than 
5
July 31 of every odd-numbered year beginning with 
6
the first such year after the date of submission of 
7
the first Strategic Federal Plan to Improve Diag-
8
nosis under paragraph (1), the Council shall pre-
9
pare, submit to the Secretary and Congress, and 
10
make publicly available an updated Strategic Fed-
11
eral Plan to Improve Diagnosis that— 
12
(A) includes such updates as the Council 
13
determines to be appropriate; 
14
(B) includes information on the overall 
15
progress of the Federal Government in reducing 
16
barriers to research on, and supporting projects 
17
to improve, diagnosis in health care; and 
18
(C) includes administrative policy rec-
19
ommendations, and may include legislative rec-
20
ommendations, including addressing any needs 
21
for greater legislative authority to meet the ob-
22
jectives listed in subsection (b). 
23
16:30 Jul 03, 2022
H8172
13 
•HR 8172 IH
(e) AUTHORIZATION OF APPROPRIATIONS.—To carry 
1
out this section, there are authorized to be appropriated 
2
$1,500,000 for each of fiscal years 2023 through 2027. 
3
SEC. 7. NATIONAL ACADEMIES REPORT. 
4
(a) IN GENERAL.—The Director of the Agency for 
5
Healthcare Research and Quality shall seek to enter into 
6
a contract with the National Academies of Sciences, Engi-
7
neering, and Medicine under which such National Acad-
8
emies conducts a study and issues a report on disparities 
9
in diagnostic safety and quality that— 
10
(1) identifies what is known about the burden 
11
and causes of such disparities, including racial, eth-
12
nic, socioeconomic, age, gender, geography, language 
13
proficiency, and intersectional interactions; and 
14
(2) includes recommendations on specific ac-
15
tions that policymakers, researchers, clinicians, and 
16
other stakeholders can take to eliminate such bur-
17
dens. 
18
(b) AUTHORIZATION OF APPROPRIATIONS.—To carry 
19
out this section, there is authorized to be appropriated 
20
$1,500,000 for fiscal year 2023, to remain available until 
21
expended. 
22
Æ 
16:30 Jul 03, 2022
H8172
